|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Salaries, wages and benefits (including equity-based compensation expense of $31,708, $37,113, and $32,289, respectively) | |||||
| Professional fees | |||||
| Supplies | |||||
| Rents and leases | |||||
| Other operating expenses | |||||
| Income from provider relief fund | |||||
| Depreciation and amortization | |||||
| Interest expense, net | |||||
| Legal settlements expense | |||||
| Loss on impairment | |||||
| Gain on sale of property | |||||
| Transaction, legal and other costs | |||||
| Total expenses | |||||
| (Loss) income before income taxes | |||||
| Provision for (benefit from) income taxes | |||||
| (Loss) income from continuing operations | |||||
| Net (loss) income | |||||
| Net income attributable to noncontrolling interests | |||||
| Net (loss) income attributable to Acadia Healthcare Company, Inc. | |||||
| (Loss) income from continuing operations attributable to Acadia Healthcare Company, Inc. | |||||
| (Loss) earnings per share attributable to Acadia Healthcare Company, Inc. stockholders: | |||||
| Basic | |||||
| (Loss) income from continuing operations attributable to Acadia Healthcare Company, Inc. | |||||
| Diluted | |||||
| Weighted-average shares outstanding: | |||||
| Basic | |||||
| Diluted | |||||
Loading...